ZA964270B - Use of pyrolidine derivatives in the treatment of alcoholism - Google Patents

Use of pyrolidine derivatives in the treatment of alcoholism

Info

Publication number
ZA964270B
ZA964270B ZA964270A ZA964270A ZA964270B ZA 964270 B ZA964270 B ZA 964270B ZA 964270 A ZA964270 A ZA 964270A ZA 964270 A ZA964270 A ZA 964270A ZA 964270 B ZA964270 B ZA 964270B
Authority
ZA
South Africa
Prior art keywords
pct
alcoholism
treatment
sec
derivatives
Prior art date
Application number
ZA964270A
Other languages
English (en)
Inventor
Asunta Imperato
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of ZA964270B publication Critical patent/ZA964270B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
ZA964270A 1995-06-01 1996-05-27 Use of pyrolidine derivatives in the treatment of alcoholism ZA964270B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9506530A FR2734724B1 (fr) 1995-06-01 1995-06-01 Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'alcoolisme

Publications (1)

Publication Number Publication Date
ZA964270B true ZA964270B (en) 1996-08-26

Family

ID=9479586

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA964270A ZA964270B (en) 1995-06-01 1996-05-27 Use of pyrolidine derivatives in the treatment of alcoholism

Country Status (27)

Country Link
US (1) US5935980A (no)
EP (1) EP0828486B1 (no)
JP (1) JPH11511747A (no)
KR (1) KR100424997B1 (no)
CN (1) CN1186432A (no)
AT (1) ATE224190T1 (no)
AU (1) AU711625B2 (no)
BG (1) BG63189B1 (no)
BR (1) BR9608633A (no)
CA (1) CA2219455C (no)
CZ (1) CZ289344B6 (no)
DE (1) DE69623767T2 (no)
DK (1) DK0828486T3 (no)
EA (1) EA000722B1 (no)
ES (1) ES2182987T3 (no)
FR (1) FR2734724B1 (no)
GE (1) GEP19991780B (no)
HU (1) HUP9900748A3 (no)
IL (1) IL118491A (no)
NO (1) NO975488L (no)
NZ (1) NZ310488A (no)
PT (1) PT828486E (no)
RO (1) RO117297B1 (no)
SK (1) SK282063B6 (no)
UA (1) UA58492C2 (no)
WO (1) WO1996038139A1 (no)
ZA (1) ZA964270B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2744361B1 (fr) * 1996-02-07 1998-02-27 Rhone Poulenc Rorer Sa Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
FR2744363B1 (fr) * 1996-02-07 1998-02-27 Rhone Poulenc Rorer Sa Application de derives de thiazolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
FR2744362B1 (fr) * 1996-02-07 1998-02-27 Rhone Poulenc Rorer Sa Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
TW442449B (en) 1996-07-04 2001-06-23 Hoechst Ag Process for preparing 1,2-dichloroethane by direct chlorination
WO2002072582A1 (en) 2001-03-12 2002-09-19 Ortho-Mcneil Pharmaceutical, Inc. Methods for the synthesis of densely functionalized pyrrolidine template libraries
US6869335B2 (en) 2002-07-08 2005-03-22 Micron Technology, Inc. Retaining rings, planarizing apparatuses including retaining rings, and methods for planarizing micro-device workpieces
US8247438B2 (en) 2008-02-27 2012-08-21 Neuropill, Inc. Methods for treating schizophrenia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2678938B1 (fr) * 1991-07-10 1993-10-08 Rhone Poulenc Rorer Sa Derives de pyrrolidine, leur preparation et les medicaments les contenant.
GB9203790D0 (en) * 1992-02-21 1992-04-08 Merck Sharp & Dohme Therapeutic agents
FR2700166B1 (fr) * 1993-01-07 1995-02-17 Rhone Poulenc Rorer Sa Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.

Also Published As

Publication number Publication date
ATE224190T1 (de) 2002-10-15
BG102087A (en) 1998-10-30
DK0828486T3 (da) 2003-01-27
EP0828486B1 (fr) 2002-09-18
IL118491A0 (en) 1996-09-12
EA000722B1 (ru) 2000-02-28
MX9708875A (es) 1998-03-31
AU6129096A (en) 1996-12-18
CZ378597A3 (cs) 1998-03-18
CA2219455C (fr) 2009-02-24
BG63189B1 (bg) 2001-06-29
ES2182987T3 (es) 2003-03-16
SK282063B6 (sk) 2001-10-08
IL118491A (en) 2002-05-23
EP0828486A1 (fr) 1998-03-18
GEP19991780B (en) 1999-10-05
US5935980A (en) 1999-08-10
FR2734724A1 (fr) 1996-12-06
PT828486E (pt) 2002-12-31
CZ289344B6 (cs) 2002-01-16
KR100424997B1 (ko) 2004-06-23
HUP9900748A3 (en) 2000-01-28
EA199700439A1 (ru) 1998-08-27
DE69623767T2 (de) 2003-07-03
UA58492C2 (uk) 2003-08-15
CA2219455A1 (fr) 1996-12-05
NO975488D0 (no) 1997-11-28
FR2734724B1 (fr) 1997-07-04
NO975488L (no) 1998-01-19
KR19990021859A (ko) 1999-03-25
WO1996038139A1 (fr) 1996-12-05
DE69623767D1 (de) 2002-10-24
BR9608633A (pt) 1999-02-02
NZ310488A (en) 2000-07-28
AU711625B2 (en) 1999-10-21
JPH11511747A (ja) 1999-10-12
HUP9900748A1 (hu) 1999-07-28
CN1186432A (zh) 1998-07-01
RO117297B1 (ro) 2002-01-30
SK161197A3 (en) 1998-05-06

Similar Documents

Publication Publication Date Title
PL323825A1 (en) Peptidyloheterocycli compounds useful in treating diorders associated with thrombosin
AU674477B2 (en) Heterocyclic-cyclic amine derivatives
AU7321598A (en) Use of cholinesterase inhibitors to treat disorders of attention
ATE148130T1 (de) Typ-iv-dipeptidyl-aminopeptidase-inhibitoren
DK0867184T3 (da) Anvendelse af tiagabin til behandling af søvnforstyrrelser
MD1838G2 (ro) Derivaţi de 5,6-diclorbenzimidazol, procedeu de obţinere a lor, compoziţie farmaceutică şi metodă de tratament sau de prevenire a infecţiei virotice herpetice
NO943475L (no) Forbindelse for å regulere fethet i hud
YU48698A (sh) Karboksamidni derivati pirolidina, piperidina i heksahidroazepina za lečenje oboljenja na bazi tromboze
IL118167A0 (en) Pyrazolo (1,5a) pyrimidines their preparation and use
DE69316910D1 (de) Neue vitamin d derivate
ES2168294T3 (es) Derivados de tiazol o imidazol inhibidores de la reaccion de maillard.
HUT77631A (hu) Eljárás a levobupivakain és származékai rezolválására
ZA964270B (en) Use of pyrolidine derivatives in the treatment of alcoholism
BR9408244A (pt) Derivados de azabiciclo[3.2.0]heptano N-substituídos
WO1996031208A3 (de) Verwendung von substituierten piperidin- oder pyrrolidinverbindungen zur behandlung von sigma-rezeptor modulierten krankheiten
MD960168A (ro) Metodă şi compuşi pentru tratamentul infecţiilor virale
TW326033B (en) Cyanobenzenesulfenyl halide and process for preparation of 3-substituted benzisothiazole using the same
ZA949564B (en) Method for treating constipation using dimeticone.
AU4530796A (en) Treating disorders characterised by excessive cell proliferation with sclareolide
IT1275436B (it) Uso della forskolina e di estratti che la contengono per il trattamento della alcol-dipendenza
PL312966A1 (en) Derivatives of thiocarbamoil
MX9706968A (es) Compuesto de tiocarbamoilo.
PL322847A1 (en) Condensed b-carbolins
MX9706520A (es) Metodos para inhibir el cancer de ovario.
DE59911958D1 (de) Fluorierte 3,4-dihydrochinolin-derivative als nos-inhibitoren